Syncom Formulations Publishes Extract of Audited Financial Results for Quarter/Year Ended 31 Mar 2026
Syncom Formulations released a press clipping on 23rd May 2026, concerning audited financial results for the quarter and year ended 31st March 2026. The Audit Committee and Board of Directors approved the results on 22nd May 2026. The advertisement was published in the "Business Standard" Journal.
This is a standard disclosure and doesn't contain information that would significantly impact the company's stock or operations.
The announcement is a routine disclosure of newspaper publication regarding financial results.
Syncom Formulations (India) Limited has released a press clipping on 23rd May 2026, regarding the extract of audited standalone and consolidated financial results for the quarter and year ended on 31st March 2026. These results were approved by the Audit Committee and Board of Directors in their meeting held on Friday, 22nd May 2026. The newspaper advertisement was published on 23rd May 2026, in the "Business Standard" Journal English Edition and Marathi (vernacular) Newspaper. The advertisement includes a Quick Response code and a weblink to access complete financial results for the said period, also available on the company's website.
What to do with a filing like this
Syncom Formulations (India) Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Syncom Formulations (India) Limited. Read the original for the full detail.